Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
0.41
- 0.00 (-0.65%)
4:00 PM ET on Mar 24, 2017
Delayed at least 20 minutes.
Day High 0.42
Day Low 0.40
52-Week High 4.40
Volume 1,838,683
Print Friendly